Status:

UNKNOWN

Neurococognitive and Functioal Assessment of Patients With Brain Metastases

Lead Sponsor:

Thomas Jefferson University

Conditions:

Cerebral Metastases Patients

Eligibility:

All Genders

18-70 years

Brief Summary

The investigators seek to perform an observational study in patients with brain metastases that are to undergo whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) treatment in orde...

Detailed Description

This research protocol is designed to perform neuropsychological testing and fMRI scanning in patients with brain metastases that are to undergo either WBRT or SRS treatment at Thomas Jefferson Univer...

Eligibility Criteria

Inclusion

  • Patients with a cumulative intracranial disease burden of up to but not exceeding 8cc.
  • Patients with newly diagnosed brain metastases are undergoing WBRT or SRS as previously determined by their oncologist and or radiation oncologist.
  • Right or left hand dominance.
  • Karnofsky performance status (KPS) equal to or greater than 70.
  • 70 years old or younger.
  • All non-hematopoietic histologies except melanoma and renal cell carcinoma.
  • Brainstem lesions are acceptable.
  • Normal renal function to tolerate a contrast enhanced MRI scan.
  • Patients must provide study specific informed consent prior to study entry.

Exclusion

  • Age less than 18 years old.
  • KPS \<70.
  • Pregnant female.
  • Active systemic disease.
  • Age greater than 70 years old.
  • Patients with leptomeningeal metastases.
  • Contraindication for MRI such as implanted metal devices, foreign bodies or severe claustrophobia or axial back pain precluding a prolonged MRI study.
  • Prior radiation therapy to the brain.
  • Poor renal function rendering contrast enhanced MRI un-obtainable.
  • Histological diagnosis of small cell lung cancer.
  • Craniotomy or other major surgery within 2 weeks of start of either SRS or WBRT.

Key Trial Info

Start Date :

March 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01861405

Start Date

March 1 2013

Last Update

December 18 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States, 19107

Neurococognitive and Functioal Assessment of Patients With Brain Metastases | DecenTrialz